Medical condition
Epilepsy
Epilepsy is a medical condition tracked by NovaPharmaNews across 11 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- lacosamide (LACOMED) Nervous system (N03)
- vigabatrin (SABRIL) Nervous system (N03)
- brivaracetam (BRIVIACT) Nervous system (N03)
- pregabalin (APO-PREGABALIN) Nervous system (N02)
- levetiracetam (APO-LEVETIRACETAM) Nervous system (N03)
- perampanel (FYCOMPA) Nervous system (N03)
- stiripentol (DIACOMIT) Nervous system (N03)
- cenobamate (ONTOZRY) Nervous system (N03)
- midazolam (PFIZER AUSTRALIA PTY LTD) Nervous system (N05)
- zonisamide (ZONEGRAN) Nervous system (N03)
- retigabine (TROBALT) Nervous system (N03)
Latest Epilepsy news
Lunai Bioworks and BrainStorm Therapeutics Launch AI Collaboration for Parkinson's and Rare Epilepsy
Lunai Bioworks and BrainStorm Therapeutics have launched a new AI discovery collaboration funded by a foundation, focusing on Parkinson's disease and rare epilepsy. This initiative aims to leverage AI technology to accelerate drug discovery and development.
AI and Brain Organoids Combat Parkinson's and Rare Epilepsy
Recent collaborations between AI technology and brain organoids aim to tackle Parkinson's disease and rare epilepsy. This article covers the latest regulatory updates and implications for the pharmaceutical industry.
UCB Acquires Neurona Therapeutics for NRTX-1001 Epilepsy Cell Therapy in $XXX Million Deal
UCB announces acquisition of Neurona Therapeutics and lead epilepsy cell therapy NRTX-1001, currently in Phase I/II trials for treatment-resistant epilepsy patients.